Jul 29, 2018
Dr. Robin Carhart-Harris speaks about the use of psilocybin for treatment-resistant depression. Here are some key points from this interview:
- Psilocybin, a psychedelic, is a 5-HT2A agonist. Stimulation of the 5-HT2A receptor promotes neural plasticity
-A potential mechanism of action of psilocybin...
Jul 29, 2018
At the 2018 Annual Meeting of the American Psychiatric Association, Dr. Robert Patterson (psychiatrist at McLean Hospital Boston) spoke about the benefits of following a structured approach to psychopharmacology.
In this episode, Dr. Patterson explains why algorithms are good for patient outcomes and how they support...